List of Tables
Table 1. Intermediate CDMO Market Trends
Table 2. Intermediate CDMO Market Drivers & Opportunity
Table 3. Intermediate CDMO Market Challenges
Table 4. Intermediate CDMO Market Restraints
Table 5. Global Intermediate CDMO Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Intermediate CDMO Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Intermediate CDMO Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Intermediate CDMO Product Type
Table 9. Key Companies Time to Begin Mass Production of Intermediate CDMO
Table 10. Global Intermediate CDMO Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intermediate CDMO as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Intermediate CDMO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Intermediate CDMO Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Intermediate CDMO Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Intermediate CDMO Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Intermediate CDMO Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Intermediate CDMO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Intermediate CDMO Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Intermediate CDMO Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Intermediate CDMO Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Intermediate CDMO Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Intermediate CDMO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Intermediate CDMO Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Intermediate CDMO Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Intermediate CDMO Sales Value by Region (2019-2024) & (%)
Table 27. Global Intermediate CDMO Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Intermediate CDMO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Intermediate CDMO Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Intermediate CDMO Sales Value, (2025-2030) & (US$ Million)
Table 31. Pharmira Basic Information List
Table 32. Pharmira Description and Business Overview
Table 33. Pharmira Intermediate CDMO Products, Services and Solutions
Table 34. Revenue (US$ Million) in Intermediate CDMO Business of Pharmira (2019-2024)
Table 35. Pharmira Recent Developments
Table 36. AGC Inc Basic Information List
Table 37. AGC Inc Description and Business Overview
Table 38. AGC Inc Intermediate CDMO Products, Services and Solutions
Table 39. Revenue (US$ Million) in Intermediate CDMO Business of AGC Inc (2019-2024)
Table 40. AGC Inc Recent Developments
Table 41. Blue Jet Healthcare Basic Information List
Table 42. Blue Jet Healthcare Description and Business Overview
Table 43. Blue Jet Healthcare Intermediate CDMO Products, Services and Solutions
Table 44. Revenue (US$ Million) in Intermediate CDMO Business of Blue Jet Healthcare (2019-2024)
Table 45. Blue Jet Healthcare Recent Developments
Table 46. Drug Discovery Alliances Basic Information List
Table 47. Drug Discovery Alliances Description and Business Overview
Table 48. Drug Discovery Alliances Intermediate CDMO Products, Services and Solutions
Table 49. Revenue (US$ Million) in Intermediate CDMO Business of Drug Discovery Alliances (2019-2024)
Table 50. Drug Discovery Alliances Recent Developments
Table 51. KriSan Biotech Basic Information List
Table 52. KriSan Biotech Description and Business Overview
Table 53. KriSan Biotech Intermediate CDMO Products, Services and Solutions
Table 54. Revenue (US$ Million) in Intermediate CDMO Business of KriSan Biotech (2019-2024)
Table 55. KriSan Biotech Recent Developments
Table 56. Saurav Chemicals Basic Information List
Table 57. Saurav Chemicals Description and Business Overview
Table 58. Saurav Chemicals Intermediate CDMO Products, Services and Solutions
Table 59. Revenue (US$ Million) in Intermediate CDMO Business of Saurav Chemicals (2019-2024)
Table 60. Saurav Chemicals Recent Developments
Table 61. Olon SpA Basic Information List
Table 62. Olon SpA Description and Business Overview
Table 63. Olon SpA Intermediate CDMO Products, Services and Solutions
Table 64. Revenue (US$ Million) in Intermediate CDMO Business of Olon SpA (2019-2024)
Table 65. Olon SpA Recent Developments
Table 66. AGC Biologics Basic Information List
Table 67. AGC Biologics Description and Business Overview
Table 68. AGC Biologics Intermediate CDMO Products, Services and Solutions
Table 69. Revenue (US$ Million) in Intermediate CDMO Business of AGC Biologics (2019-2024)
Table 70. AGC Biologics Recent Developments
Table 71. Fermion Basic Information List
Table 72. Fermion Description and Business Overview
Table 73. Fermion Intermediate CDMO Products, Services and Solutions
Table 74. Revenue (US$ Million) in Intermediate CDMO Business of Fermion (2019-2024)
Table 75. Fermion Recent Developments
Table 76. Pfizer CentreOne Basic Information List
Table 77. Pfizer CentreOne Description and Business Overview
Table 78. Pfizer CentreOne Intermediate CDMO Products, Services and Solutions
Table 79. Revenue (US$ Million) in Intermediate CDMO Business of Pfizer CentreOne (2019-2024)
Table 80. Pfizer CentreOne Recent Developments
Table 81. Aspen Holdings Basic Information List
Table 82. Aspen Holdings Description and Business Overview
Table 83. Aspen Holdings Intermediate CDMO Products, Services and Solutions
Table 84. Revenue (US$ Million) in Intermediate CDMO Business of Aspen Holdings (2019-2024)
Table 85. Aspen Holdings Recent Developments
Table 86. Educell Basic Information List
Table 87. Educell Description and Business Overview
Table 88. Educell Intermediate CDMO Products, Services and Solutions
Table 89. Revenue (US$ Million) in Intermediate CDMO Business of Educell (2019-2024)
Table 90. Educell Recent Developments
Table 91. Hovione Basic Information List
Table 92. Hovione Description and Business Overview
Table 93. Hovione Intermediate CDMO Products, Services and Solutions
Table 94. Revenue (US$ Million) in Intermediate CDMO Business of Hovione (2019-2024)
Table 95. Hovione Recent Developments
Table 96. Porton Pharma Solutions Basic Information List
Table 97. Porton Pharma Solutions Description and Business Overview
Table 98. Porton Pharma Solutions Intermediate CDMO Products, Services and Solutions
Table 99. Revenue (US$ Million) in Intermediate CDMO Business of Porton Pharma Solutions (2019-2024)
Table 100. Porton Pharma Solutions Recent Developments
Table 101. Sinopep Basic Information List
Table 102. Sinopep Description and Business Overview
Table 103. Sinopep Intermediate CDMO Products, Services and Solutions
Table 104. Revenue (US$ Million) in Intermediate CDMO Business of Sinopep (2019-2024)
Table 105. Sinopep Recent Developments
Table 106. Chongqing Huapont Pharmaceutical Basic Information List
Table 107. Chongqing Huapont Pharmaceutical Description and Business Overview
Table 108. Chongqing Huapont Pharmaceutical Intermediate CDMO Products, Services and Solutions
Table 109. Revenue (US$ Million) in Intermediate CDMO Business of Chongqing Huapont Pharmaceutical (2019-2024)
Table 110. Chongqing Huapont Pharmaceutical Recent Developments
Table 111. Langhua Pharmaceutical Basic Information List
Table 112. Langhua Pharmaceutical Description and Business Overview
Table 113. Langhua Pharmaceutical Intermediate CDMO Products, Services and Solutions
Table 114. Revenue (US$ Million) in Intermediate CDMO Business of Langhua Pharmaceutical (2019-2024)
Table 115. Langhua Pharmaceutical Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Intermediate CDMO Downstream Customers
Table 119. Intermediate CDMO Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Intermediate CDMO Product Picture
Figure 2. Global Intermediate CDMO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intermediate CDMO Sales Value (2019-2030) & (US$ Million)
Figure 4. Intermediate CDMO Report Years Considered
Figure 5. Global Intermediate CDMO Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Intermediate CDMO Revenue in 2023
Figure 7. Intermediate CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antibiotic Intermediates Picture
Figure 9. Antipyretic and Analgesic Intermediate Picture
Figure 10. Cardiovascular System Drug Intermediates Picture
Figure 11. Anticancer Drug Intermediates Picture
Figure 12. Global Intermediate CDMO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Intermediate CDMO Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Pharmaceutical Company
Figure 15. Product Picture of Biotechnology Company
Figure 16. Product Picture of Generic Company
Figure 17. Product Picture of Others
Figure 18. Global Intermediate CDMO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Intermediate CDMO Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Intermediate CDMO Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Intermediate CDMO Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Intermediate CDMO Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Intermediate CDMO Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Intermediate CDMO Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Intermediate CDMO Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Intermediate CDMO Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Intermediate CDMO Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Intermediate CDMO Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Intermediate CDMO Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Intermediate CDMO Sales Value (%), (2019-2030)
Figure 31. United States Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 37. China Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 39. China Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 49. India Intermediate CDMO Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Intermediate CDMO Sales Value by Type (%), 2023 VS 2030
Figure 51. India Intermediate CDMO Sales Value by Application (%), 2023 VS 2030
Figure 52. Intermediate CDMO Industrial Chain
Figure 53. Intermediate CDMO Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
